950 related articles for article (PubMed ID: 28953820)
21. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.
Park SC; Lee MS; Kang SG; Lee SH
J Korean Med Sci; 2014 May; 29(5):719-28. PubMed ID: 24851031
[TBL] [Abstract][Full Text] [Related]
22. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
23. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
24. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
Schreiner A; Caspi A; Bergmans P; Cherubin P; Keim S; Lara E; Pinchuk I; Schuepbach D; Suleman S; Hargarter L
Psychopharmacology (Berl); 2017 Jan; 234(1):3-13. PubMed ID: 27815602
[TBL] [Abstract][Full Text] [Related]
25. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
26. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT
Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States.
Martin A; Bessonova L; Hughes R; Doane MJ; O'Sullivan AK; Snook K; Cichewicz A; Weiden PJ; Harvey PD
Adv Ther; 2022 Sep; 39(9):3933-3956. PubMed ID: 35844007
[TBL] [Abstract][Full Text] [Related]
28. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
29. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
30. Explicit review of risperidone long-acting injection prescribing practice.
Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
[TBL] [Abstract][Full Text] [Related]
31. Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
Wheeler A
N Z Med J; 2006 Jul; 119(1237):U2055. PubMed ID: 16862201
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic use in children and adolescents: a 1-year follow-up study.
Baeza I; de la Serna E; Calvo-Escalona R; Morer A; Merchán-Naranjo J; Tapia C; Martínez-Cantarero MC; Andrés P; Alda JA; Sánchez B; Arango C; Castro-Fornieles J
J Clin Psychopharmacol; 2014 Oct; 34(5):613-9. PubMed ID: 25154009
[TBL] [Abstract][Full Text] [Related]
33. Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
Cleymans S; Morrens M; Bervoets C
J Med Ethics; 2017 Jun; 43(6):359-363. PubMed ID: 27895084
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Mukundan A; Faulkner G; Cohn T; Remington G
Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
[TBL] [Abstract][Full Text] [Related]
35. Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection.
Heald AH; Stedman M; Farman S; Khine C; Davies M; De Hert M; Taylor D
BMC Psychiatry; 2020 Nov; 20(1):528. PubMed ID: 33160310
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
[TBL] [Abstract][Full Text] [Related]
37. Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses.
Højlund M; Andersen JH; Andersen K; Correll CU; Hallas J
Epidemiol Psychiatr Sci; 2021 Apr; 30():e28. PubMed ID: 33820580
[TBL] [Abstract][Full Text] [Related]
38. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
39. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries.
Szkultecka-Dębek M; Miernik K; Stelmachowski J; Jakovljević M; Jukić V; Aadamsoo K; Janno S; Bitter I; Tolna J; Jarema M; Jankovic S; Pecenak J; Vavrusova L; Tavčar R; Walczak J; Talbot D; Augustyńska J
Psychiatr Danub; 2016 Sep; 28(3):234-242. PubMed ID: 27658832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
